Yakuodo Holdings Co., Ltd. AI Stock Analysis
Want to see JP:7679 full AI Analyst Report?
Yakuodo Holdings Co., Ltd. (7679) AI Stock Analysis
Yakuodo Holdings Co., Ltd.
(TSE/TYO:7679)
Yakuodo Holdings scores in the below-average range. The main drag is financial quality: despite steady revenue growth, margins are compressing, FY2026 net income is set to fall, debt has nearly doubled, and free cash flow has turned deeply negative at -¥8.28 billion, signalling an aggressive and currently unprofitable investment phase. Technicals reinforce the caution, with the shares trading below all major moving averages and a negative MACD. The offsetting positive is valuation — a 7.6x P/E, a 1.89% dividend yield, and low beta suggest meaningful pessimism is already reflected in the price, which supports the score but is not enough to offset the weakening fundamentals and downtrend.
Yakuodo Holdings Co., Ltd. (7679) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 30.07B
- Dividend Yield
- 1.88%
- Average Volume (3M)
- 71.93K
- Price to Earnings (P/E)
- 8.2
- Beta (1Y)
- 0.43
- Revenue Growth
- 8.08%
- EPS Growth
- -15.52%
- Country
- Japan
- Employees
- 1,094
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Pharmaceuticals
Yakuodo Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
YAKUODO HOLDINGS Co., Ltd., through its subsidiaries, engages in drugstore business in Japan. It retails health products, including energy drinks, cold medicine, disposable diapers for nursing care, and sanitary products; beauty products comprising s...
Yakuodo Holdings Co., Ltd. Financial Statement Overview
Summary
Revenue growth remains solid at roughly 7-10% annually, reflecting successful store expansion, and equity has built steadily with ROE in the 10-13% range. However, the quality of earnings is deteriorating: gross margins have compressed from ~23.2% to ~19.5%, net income is estimated to decline in FY2026 despite higher sales, total debt nearly doubled to ¥34.6 billion (debt/equity rising to ~0.86), and free cash flow swung sharply negative to -¥8.28 billion. The combination of thin ~2.5-3.0% net margins, rising leverage, and heavy cash burn outweighs the top-line strength.
Income Statement
55NeutralBalance Sheet
42NeutralCash Flow
35Negative| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 170.75B | 163.81B | 151.96B | 142.24B | 128.79B | 110.53B |
| Gross Profit | 33.02B | 31.71B | 29.66B | 27.86B | 25.45B | 23.27B |
| EBITDA | 9.04B | 8.97B | 8.71B | 8.16B | 7.56B | 7.36B |
| Net Income | 3.73B | 4.03B | 4.28B | 3.83B | 3.24B | 3.29B |
Balance Sheet | ||||||
| Total Assets | 118.97B | 103.17B | 80.26B | 71.07B | 68.01B | 60.90B |
| Cash, Cash Equivalents and Short-Term Investments | 18.80B | 10.01B | 7.17B | 4.95B | 5.28B | 9.14B |
| Total Debt | 37.87B | 34.60B | 18.19B | 13.60B | 15.75B | 16.30B |
| Total Liabilities | 77.07B | 62.94B | 43.19B | 37.75B | 38.06B | 35.87B |
| Stockholders Equity | 41.90B | 40.23B | 37.06B | 33.31B | 29.94B | 25.02B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -8.28B | 569.00M | 3.58B | 2.76B | 955.00M |
| Operating Cash Flow | 0 | 3.29B | 4.49B | 5.63B | 6.41B | 5.21B |
| Investing Cash Flow | 0 | -12.84B | -4.57B | -2.27B | -4.11B | -4.98B |
| Financing Cash Flow | 0 | 12.40B | 2.30B | -3.69B | -1.27B | 6.95B |
Yakuodo Holdings Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7679, the sentiment is Negative. The current price of 1546.00 is above the 20-day moving average (MA) of 1501.15, below the 50-day MA of 1566.80, and below the 200-day MA of 1758.93, indicating a neutral trend. The MACD of -14.20 indicates Negative momentum. The RSI at 54.34 is Neutral, neither overbought nor oversold. The STOCH value of 83.01 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7679.
Yakuodo Holdings Co., Ltd. Peers Comparison
Overall Rating
JP:339181Outperform
JP:354971Outperform
JP:764969Neutral
JP:998969Neutral
JP:334959.9Neutral
JP:767950Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 81Outperform | JPY 1.13T | 20.31 | 7.13% | 1.88% | ― | ― | |
| 71Outperform | JPY 485.06B | 26.29 | ― | 0.29% | 12.54% | 15.87% | |
| 69Neutral | JPY 550.50B | 17.88 | 9.94% | 1.24% | 8.97% | -29.54% | |
| 69Neutral | JPY 458.81B | 15.65 | 11.04% | 3.36% | 3.99% | -0.48% | |
| 60Neutral | JPY 512.38B | 16.29 | ― | 1.27% | 8.99% | 3.61% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 50Neutral | JPY 30.52B | 8.20 | ― | 1.88% | 8.08% | -15.52% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7679 | Yakuodo Holdings Co., Ltd. | 1546.00 | -522.68 | -25.27% | |
| JP:9989 | Sundrug Co | 3924.00 | -170.08 | -4.15% | |
| JP:7649 | Sugi Holdings Co | 1416.50 | -362.90 | -20.39% | |
| JP:3391 | TSURUHA Holdings | 2500.00 | -205.65 | -7.60% | |
| JP:3349 | COSMOS Pharmaceutical Corporation | 6437.00 | -1107.01 | -14.67% | |
| JP:3549 | KUSURI NO AOKI HOLDINGS CO.,LTD. | 5073.00 | 1262.96 | 33.15% |
Yakuodo Holdings Co., Ltd. Corporate Events
Yakuodo October Sales Rise 6.8% as Store Network Expands
Yakuodo Holdings reported October 2026 sales growth across its store network, with total sales rising 6.8% year on year, customer numbers increasing 5.5% and average spending climbing 1.2%. Existing-store sales grew 1.1%, supported by a 1.6% increase...
Yakuodo grows sales but sees profit slide and leverage rise in first half
Yakuodo Holdings reported consolidated net sales of ¥89.76 billion for the six months ended August 31, 2026, an 8.4% year-on-year increase, but operating profit fell 5.3% to ¥3.29 billion and profit attributable to owners declined 11.8% to ¥2.23 bill...
Yakuodo’s September Sales Stay Strong as Drugstore Chain Expands to 469 Stores
Yakuodo Holdings Co., Ltd. reported solid sales momentum for September 2026, with all-store net sales up 8.5% year on year and existing-store sales rising 3.1%. Growth was driven by both higher customer numbers and increased average spending, extendi...
Yakuodo’s August Flash Report Shows Solid Sales and Ongoing Regional Expansion
Yakuodo Holdings reported that all-store net sales for March through August of the fiscal year ending February 28, 2027 rose between 2.9% and 12.5% year on year, supported by growth in both customer numbers and average spending. Existing stores also...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
